🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomised, double-blind, three-period crossover euglycaemic clam...
Status
Completed
Location
Profil Institut für Stoffwechselforschung GmbH
Start Date
2022-05-12
Trial ID
NCT05373199
Primary Objective: To compare the pharmacodynamic properties of two differ...
Status
Completed
Location
Investigational Site Number 392001
Start Date
2011-11
Trial ID
NCT01493115
Treatments Being Tested
Primary Objective: To assess the safety and tolerability of two dose level...
Status
Completed
Location
Investigational site number 276001
Start Date
2011-03
Trial ID
NCT01349855
Treatments Being Tested
Primary objectives: To demonstrate biosimilarity with regard to the total ...
Status
Completed
Location
Profil Mainz GmbH & Co. KG
Start Date
2018-07-10
Trial ID
NCT04236895
Treatments Being Tested
This is a randomised, double-blind, double-dummy, active-controlled, three-...
Status
Completed
Location
Profil Institut für Stoffwechselforschung GmbH
Start Date
2022-05-12
Trial ID
NCT05373186
This is an active- and placebo-controlled, single-site, four-part trial of ...
Status
Completed
Location
ProSciento Inc. ( Site 0001)
Start Date
2017-08-16
Trial ID
NCT03170544
The aim of this trial is to demonstrate bioequivalence of Glaritus® to Lant...
Status
Completed
Location
Profil Institute for clinical Research
Start Date
2011-06
Trial ID
NCT01357603
Treatments Being Tested
Primary Objective: To compare the pharmacokinetic (PK) characteristics of ...
Status
Completed
Location
Investigational Site Number 276001
Start Date
2014-08
Trial ID
NCT02201199
Treatments Being Tested
Primary Objective: \- To assess the total metabolic effect ratios of a new...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2010-08
Trial ID
NCT01195454
Treatments Being Tested